Phylogenetic relationships matter: Antifungal susceptibility among clinically relevant yeasts

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1575-1585

  Schmalreck, A F ^a   Lackner, M ^b   Becker, K ^c   Fegeler, W ^c   Czaika, V ^d   Ulmer, H ^b   Lass Florl C ^b  

^a MBS   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 18S; ELONGATION FACTOR 1ALPHA; FLUCONAZOLE; ITRACONAZOLE; RNA POLYMERASE II; SMALL SUBUNIT RIBOSOMAL RNA; UBIQUINONE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA SAKE; CANDIDA TROPICALIS; CANDIDA ZEYLANOIDES; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS LAURENTII; CRYPTOCOCCUS NEOFORMANS; CYBERLINDNERA JADINII; EXOPHIALA DERMATITIDIS; FUNGUS ISOLATION; GALACTOMYCES GEOTRICHUM; GENE NOMENCLATURE; GENE SEQUENCE; HANSENIASPORA; IN VITRO STUDY; KLUYVEROMYCES LACTIS; KLUYVEROMYCES MARXIANUS; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA PACHYDERMATIS; MALASSEZIA SYMPODIALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PICHIA; PICHIA NORVEGENSIS; PRIORITY JOURNAL; RHODOTORULA MUCILAGINOSA; SACCHAROMYCES CEREVISIAE; TAXONOMY; TRICHOSPORON ASAHII; WICKERHAMOMYCES ANOMALUS; YEAST; ZYGOSACCHAROMYCES BAILII;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY;

EID: 84896835040     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01799-13     Document Type: Article

References (82)

1. Hennebert GL, Weresub LK. 1977. Terms for states and forms of fungi, their names and types. Mycotaxon 6:207-211.
2. Saccardo PA. 1880. Conspectus generum fungorum Italiae inferiorum. Michelia 2:1-38.
3. Knapp S, McNeill J, Turland NJ. 2011. Changes to publication requirements made at the XVIII International Botanical Congress in Melbourne - what does e-publication mean for you? BMC Evol. Biol. 11:250. http://dx.doi.org/10.1186/ 1471-2148-11-250.
4. Gams W. 1995. How natural should anamorph genera be? Can. J. Bot. 73:747-753. http://dx.doi.org/10.1139/b95-318.
5. McNeill JM, Barrie FR, Buck WR, Demoulin V, Greuter W, Hawksworth DL, Herendeen PS, Knapp S, Marhold K, Prado J, Pru'homme van Reine WF, Smith GE, Wiersema JH, Turland N (ed). 2012. International Code of Nomenclature for Algae, Fungi, and Plants (Melbourne Code) adopted by the Eighteenth International Botanical Congress, Melbourne, Australia, July 2011. A. R. G. Gantner Verlag, Ruggell, Liechtenstein.
6. Guarro J, Gené J, Stchigel AM. 1999. Developments in fungal taxonomy. Clin. Microbiol. Rev. 12:454-500. (Pubitemid 29330140)
7. Hawksworth DL. 2011. A new dawn for the naming of fungi: impacts of decisions made in Melbourne in July 2011 on the future publication and regulation of fungal names. MycoKeys 1:7-20. http://dx.doi.org/10.3897/mycokeys. 1.2062.
8. Hawksworth DL, Crous PW, Redhead SA, Reynolds DR, Samson RA, Seifert KA, Taylor JW, Wingfield MJ, Abaci O, Aime C, Asan A, Bai FY, de Beer ZW, Begerow D, Berikten D, Boekhout T, Buchanan PK, Burgess T, Buzina W, Cai L, Cannon PF, Crane JL, Damm U, Daniel HM, van Diepeningen AD, Druzhinina I, Dyer PS, Eberhardt U, Fell JW, Frisvad JC, Geiser DM, Geml J, Glienke C, Gräfenhan T, Groenewald JZ, Groenewald M, de Gruyter J, Guého-Kellermann E, Guo LD, Hibbett DS, Hong SB, de Hoog GS, Houbraken J, Huhndorf SM, Hyde KD, Ismail A, Johnston PR, Kadaifciler DG, Kirk PM, Kõljalg U, et al. 2011. The Amsterdam declaration on fungal nomenclature. IMA Fungus 2:105-112. http://dx.doi.org/10.5598/imafungus.2011.02.01.14.
9. Novell LL. 2011. Fungal nomenclature. 1. Melbourne approves a new code. Mycotaxon 116:481-490. http://dx.doi.org/10.5248/116.481.
10. Bickford D, Lohman DJ, Navjot SS, Ng PKL, Meier R, Winker K, Ingram K, Das I. 2007. Cryptic species as a window on diversity and conservation. Trends Ecol. Evol. 22:148-155. http://dx.doi.org/10.1016/j.tree.2006.11.004. (Pubitemid 46273824)
11. Borman BM, Linton CJ, Oliver D, Palmer MD, Szekely A. 2010. Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2. J. Clin. Microbiol. 48: 3648-3653. http://dx.doi.org/10.1128/JCM.01071-10.
12. McGinnis MR, Pasarell L. 1998. In vitro testing of susceptibilities of filamentous Ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J. Clin. Microbiol. 36:2353-2355. (Pubitemid 28324097)
13. Sugita T, Takeo K, Ohkusu M, Virtudazo E, Takashima M, Asako E, Ohshima F, Harada S, Yanaka C, Nishikawa A, Majoros L, Sipiczki M. 2004. Fluconazole-resistant pathogens Candida inconspicua and C. norvegensis: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility, and extracellular enzyme production. Microbiol. Immunol. 48:761-766. http://dx.doi.org/10.1111/j.1348-0421.2004.tb03602.x. (Pubitemid 39421418)
14. Seret M-L, Diffels JF, Goffeau A, Barret PV. 2009. Combined phylogeny and neighbourhood analysis of the evolution of the ABC transporters conferring multiple drug resistance in hemiascomycete yeasts. BMC Genomics 10:459. http://dx.doi.org/10.1186/1471-2164-10-459.
15. Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G. 2011. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J. Antimicrob. Chemother. 66:2315-2322. http://dx.doi.org/10.1093/jac/dkr298.
16. Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. 2011. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob. Agents Chemother. 55:4802-4809. http://dx.doi.org/10.1128/AAC.00304-11.
17. Pfaller MA, Woosley LN, Messer SA, Jones RN, Castanheira M. 2012. Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme. Mycopathologia 174:259-271. http://dx.doi.org/10.1007 /s11046-012-9551-x.
18. de Hoog GS, Haase G, Walsh TJ, Meyer W, Lackner M. 2013. Taxonomy of medically important fungi in the molecular era. Lancet Infect. Dis. 13:385-386. http://dx.doi.org/10.1016/S1473-3099(13)70058-6.
19. Desnos-Ollivier M, Robert V, Raoux-Barbot D, Groenewald M, Dromer F. 2012. Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens. PLoS One 7:e32278. http://dx.doi.org/10.1371/journal.pone.0032278.
20. Taverna CG, Bosco-Borgeat ME, Murisengo OA, Davel G, Côrtes Boité M, Cupolillo E, Canteros CE. 2013. Comparative analyses of classical phenotypic method and ribosomal RNA gene sequencing for identification of medically relevant Candida species. Mem. Inst. Oswaldo Cruz 108: 178-185. http://dx.doi.org/10.1590/0074-0276108022013009.
21. Cordoba S, Vivot W, Bosco-Borgeat ME, Taverna C, Szusz W, Murisengo O, Isla G, Davel G, Red Nacional de Laboratorios de Micologia. 2011. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina. Rev. Argent. Microbiol. 43:176-185. http://dx.doi.org/10.1590/S0325- 75412011000300003.
22. Kurtzman CP, Robnett CJ. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223. (Pubitemid 27175254)
23. Kurtzman CP, Robnett CJ. 2012. Relationships among genera of the Saccharomycotina (Ascomycota) from multigene phylogenetic analysis of type species. FEMS Yeast Res. 101:795-802. http://dx.doi.org/10.1111/1567-1364.12006.
24. Suh S-O, Blackwell M, Kurtzman CP, Lachance MA. 2006. Phylogenetics of Saccharomycetales, the ascomycete yeasts. Mycologia 98:1006-1017. http://dx.doi.org/10.3852/mycologia.98.6.1006. (Pubitemid 46683222)
25. Schweigkofler W, Lopandic K, Molnár O, Prillinger H. 2002. Analysis of phylogenetic relationships among Ascomycota with yeast phases using ribosomal DNA sequences and cell wall sugars. Organisms Diversity Evol. 2:1-17. http://dx.doi.org/10.1078/1439-6092-00029.
26. Diezmann S, Cox CJ, Schönian Vilgalys RJ, Mitchell TG. 2004. Phylogeny and evolution of medical species of Candida and related taxa: a multigenic analysis. J. Clin. Microbiol. 42:5624-5635. http://dx.doi.org/10. 1128/JCM.42.12.5624-5635.2004. (Pubitemid 39664346)
27. Ciardo DE, Schär G, Böttger EC, Altwegg M, Bosshard PP. 2006. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J. Clin. Microbiol. 44:77-84. http://dx.doi.org/10.1128/JCM.44.1.77-84.2006. (Pubitemid 43100583)
28. Fischer G, Rocha EPC, Brunet F, Vergassola M, Dujon B. 2006. Highly variable rates of genome rearrangements between hemiascomycetous yeast lineages. PLoS Genet. 2:e32. http://dx.doi.org/10.1371/journal.pgen.0020032.
29. Tsui KM, Daniel H-M, Robert V, Meyer W. 2008. Re-examining the phylogeny of clinically relevant Candida species and allied genera based on multigene analysis.FEMSYeast Res. 8:651-659. http://dx.doi.org/10.1111/j.1567-1364.2007. 00342.x.
30. Liu YJ, Hodson MC, Hall BD. 2006. Loss of the flagellum happened only once in the fungal lineage: phylogenetic structure of kingdom Fungi inferred from RNA polymerase II subunit genes. BMC Evol. Biol. 6:74. http://dx.doi.org/ 10.1186/1471-2148-6-74.
31. Odronitz F, Kollmar M. 2007. Drawing the tree of eukaryotic life based on the analysis of 2,269 manually annotated myosins from 328 species. Genome Biol. 8:R196. http://dx.doi.org/10.1186/gb-2007-8-9-r196.
32. Marinoni G, Lachance MA. 2004. Specification in the large-spored Metschnikowia clade and establishment of a new species, Metschnikowia borealis comb. nov. FEMS Yeast Res. 4:587-596. http://dx.doi.org/10.1016/j.femsyr.2003. 12.005.
33. Lachance MA. 2007. Current status of Kluyveromyces systematics. FEMS Yeast Res. 7:642-645. http://dx.doi.org/10.1111/j.1567-1364.2006.00197.x.
34. de Hoog GS, Smith MTH. 2004. Ribosomal gene phylogeny and species delimitation in Geotrichum and its teleomorphs. Stud. Mycol. 50:489-515.
35. Nagahama T, Abdel-Wahab MA, Nogy Y, Miyazaki M, Uematsu K, Hamamoto M, Horikoshi K. 2008. Dipodascus tetrasporeus sp. nov., an ascosporogenous yeast isolated from deep-sea sediments in the Japan Trench. Int. J. Syst. Evol. Microbiol. 58:1040-1046. http://dx.doi.org/10.1099/ijs.0.65471-0.
36. Kurtzman CP, Robnett CJ, Basehoar-Powers E. 2008. Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen. nov. FEMS Yeast Res. 8:939-954. http://dx.doi.org/10.1111/j.1567-1364.2008.00419.x.
37. de Hoog GS, Vicente V, Caligiorne RB, Kantarcioglu S, Tintelnot K, Gerrits van den Ende AH, Haase G. 2003. Species diversity and polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. J. Clin. Microbiol. 41:4767-4778. http://dx.doi.org/10.1128/JCM.41.10.4767-4778. 2003.
38. Fell JW, Roeijmans Boekhout T. 1999. Cystofilobasdiales, a new order of basidiomycetous yeasts. Int. J. Syst. Bacteriol. 49:907-913. http://dx.doi.org/10.1099/00207713-49-2-907. (Pubitemid 29222385)
39. Sugita T, Nishikawa A, Ikeda R, Shinoda T. 1999. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J. Clin. Microbiol. 37:1985-1993. (Pubitemid 29235259)
40. Colombo AL, Padovan ACB, Chaves GM. 2011. Current knowledge of Trichosporon spp. and trichosporonosis. Clin. Microbiol. Rev. 24:682-700. http://dx.doi.org/10.1128/CMR.00003-11.
41. Sampaio JP, Gadanho M, Santos S, Duarte FL, Pais C, Fonseca A, Fell JW. 2001. Polyphasic taxonomy of the basidiomycetous yeast genus Rhodosporidium: Rhodosporidium kratochvilae and related anamorphic species. Int. J. Syst. Evol. Microbiol. 51:687-697. http://dx.doi.org/10.1099/00207713-51-2-687. (Pubitemid 32266712)
42. Findley K, Rodriguez-Carres M, Metin B, Kroiss J, Fonseca A, Vilgalys R, Heitman J. 2009. Phylogeny and phenotypic characterization of pathogenic Cryptococcus species and closely related saprobic taxa in the Tremellales. Eukaryot. Cell 8:353-361. http://dx.doi.org/10.1128/EC.00373-08.
43. Caligiorne RB, Licinio P, Dupont J, de Hoog GS. 2005. Internal transcribed spacer rRNA gene-based phylogenetic reconstruction using algorithms with local and global sequence alignment for black yeasts and their relatives. J. Clin. Microbiol. 43:2816-2823. http://dx.doi.org/10.1128/JCM.43.6.2816-2823. 2005. (Pubitemid 40827959)
44. Suzuki M, Nakase T. 1998. Cellular neutral sugar composition and ubiquinone systems of the genus Candida. Microb. Cult. Coll. 14:49-62.
45. Suzuki M, Nakase T. 2002. A phylogenetic study of ubiquinone-7 species of the genus Candida based on 18S ribosomal DNA sequence divergence. J. Gen. Appl. Microbiol. 48:55-65. http://dx.doi.org/10.2323/jgam.48.55. (Pubitemid 34846246)
46. Kurtzman CP. 2011. Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalus. Antonie Van Leeuwenhoek 99:13-23. http://dx.doi.org/10.1007/s10482-010-9505-6.
47. Schmalreck AF, Willinger G, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group. 2012. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multicentre study. Mycoses 55:e124-e137. http://dx.doi.org/10.1111/j.1439-0507.2011.02165.x.
48. Deutsches Institut für Normung. 2002. DIN 58940-84 Medizinische Mikrobiologie-Empfindlichkeitsprüfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika. Teil 84. Mikrodilution; Spezielle Anforderungen an die Testung von Pilzen gegen Antimykotika. Released October 2002. Beuth Verlag, Berlin, Germany. (In German.)
49. Czaika V, Nenoff P, Glöckner A, Czaika V, Nenoff P, Glöckner A, Fegeler W, Becker K, Schmalreck AF. 2013. Clinical yeast isolates related to dermatology, gynaecology, and paediatrics. Susceptibility profiles of azoles and changes in parallel-resistance from 1997 up to 2009. Int. J. Microbiol. http://dx.doi.org/10.1155/2013/703905.
50. Schmalreck AF, Willinger B, Czaika V, Fegeler W, Becker K, Blum K, Lass-Flörl C. 2012. Susceptibility screening of hyphae-forming fungi with a new, easy, and fast inoculum preparation method. Mycopathologia 174: 467-474. http://dx.doi.org/10.1007/s11046-012-9570-7.
51. Deutsches Institut für Normung. 2007. DIN-Fachbericht 157. Rationale für Bewertungskriterien für minimale Hemmkonzentrationen (MHK) und Hemmzonendurchmesser (HZD) von Fluconazol entsprechend DIN 58940 bei klinisch relevanten Sprosspilzen, sowie Festlegung von Flucona-zol- (Grenz)- Kontrollwerten für Kontrollstämme. Released December 2007. Beuth Verlag, Berlin, Germany. (In German.)
52. EUCAST. Fluconazole, rationale for the EUCAST clinical breakpoints. EUCAST, Basel, Switzerland. http://www.eucast.org/fileadmin/src/media/PDFs/ EUCAST-files/Rationale-documents/Fluconazole-rationale-2-0-20130223.pdf.
53. European Committee on Antibiotic Susceptibility. 2002. Method for determination of minimal inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Discussion document E. Dis. 7.1. European Society of Clinical Microbiology and Infectious Diseases, Taufkirchen, Germany.
54. Saraiva RG, Lopes JA, Machado J, Gameiro P, Feio MJ. 26 November 2012. Discrimination of single-porin Escherichia (E.) coli mutants by ATR and transmission mode FTIR spectroscopy. J. Biophotonics [Epub ahead of print.] http://dx.doi.org/10.1002/jbio.201200131.
55. Alvarez-Ordóñez A, Prieto M. 2012. Fourier transform infrared spectroscopy to assist in taxonomy and identification of foodborne microorganisms, p 19-21. In Springer briefs in food, health, and nutrition. Springer Verlag, Berlin, Germany.
56. Subburaj J, Barathkumar TR, Prem V, Thangaraj M, Sivasubramanian J. 2013. Spectroscopic analysis of five phylogenetically distant fungi (division: Ascomycete) from Vellar Estuary, Southeast Coast of India-a pilot study. J. Microbiol. Biotechnol. Food Sci. 2:2355-2359.
57. Suzuki M, Suh OH, Sugita T, Nakase T. 1999. A phylogenetic study on galactose containing Candida species based on 18S ribosomal DNA sequences. J. Gen. Appl. Microbiol. 45:229-238. http://dx.doi.org/10.2323/jgam.45.229. (Pubitemid 30189447)
58. Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. 2001. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses 44:437-445. http://dx.doi.org/10.1046/j.1439-0507.2001.00707.x. (Pubitemid 34131789)
59. Bastert J, Korting HC, Tränkle P, Schmalreck AF. 1999. Identification of dermatophytes by Fourier-transform infrared-spectroscopy (FT-IR). Mycoses 43:525-528.
60. Schmalreck AF, Hotzel H. 2000. Fourier-Transform-Infrarot-Spektroskopie, molekular-biologische Methoden und Antimykotika-Empfindlichkeitsmuster zur Identifizierung und Differenzierung von Cryptococcus-Spezies. Mycoses 43(Suppl 1):61-68. (In German.) http://dx.doi.org/10.1111/j.1439-0507.1998.tb00587.x.
61. Kielstein P, Hotzl H, Schmalreck A, Khaschabi D, Glawischnig D. 2000. Occurrence of Cryptococcus spp. in excreta of pigeons and pet birds. Mycoses 43:7-15. http://dx.doi.org/10.1046/j.1439-0507.2000.00534.x. (Pubitemid 30336850)
62. Kalinowska-Pujdak A, Schmalreck A, Haustein UF, Nenoff P. 2006. Species differentiation of yeasts of the genus Malassezia with Fourier transform infrared spectroscopy. Hautarzt 57:127-136. http://dx.doi.org/10.1007/s00105- 005-1018-2. (Pubitemid 43252085)
63. White TJ, Burns TD, Lee SB, Taylor JW. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p 315-322. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (ed), PCR protocols. A guide to methods and applications. Academic Press Inc, San Diego, CA.
64. Lau A, Chen S, Sorrell T, Carter D, Malik R, Martin P, Halliday C. 2007. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J. Clin. Microbiol. 45:380-385. http://dx.doi.org/10.1128/JCM.01862-06.
65. Haase G, Sonntag L, Krick B, de Hoog GS. 1999. Phylogenetic inference by SSU gene analysis of members of the Herpotrichiellaceae with special reference to human pathogenic species. Stud. Mycol. 43:80-97.
66. Suh SO, Sugiyama J. 1993. Phylogeny among the basidiomycetous yeasts inferred from small subunit ribosomal DNA sequence. J. Gen. Microbiol. 139:1595-1598. http://dx.doi.org/10.1099/00221287-139-7-1595. (Pubitemid 23239084)
67. Scorzetti G, Fell JW, Fonseca A, Statzell-Tallman A. 2002. Systematics of basidiomycetous yeasts: a comparison of large subunit D1/D2 and internal transcribed spacer rDNA regions. FEMS Yeast Res. 2:495-517. http://dx.doi.org/ 10.1111/j.1567-1364.2002.tb00117.x.
68. Schmalreck AF, Tränkle P, Vanca E, Blaschke-Hellmessen R. 1998. Differenzierung und Charakterisierung von humanpathogenen Hefen (Candida albicans, Exophiala dermatitidis) und tierpathogenen Algen (Prototheca spp.) mittels Fourier-Transform-Infrarot-Spektroskopie (FT-IR) im Vergleich zu konventionellen Methoden. Mycoses 41(Suppl 1):1-77. (In German.)
69. Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, Nachbaur D. 2012. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J. Antimicrob. Chemother. 67: 2268-2273. http://dx.doi.org/10.1093/jac/dks189.
70. Perkhofer S, Lass-Flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. 2010. The nationwide Austrian Aspergillus registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int. J. Antimicrob. Agents 36:531-536. http://dx.doi.org/10.1016/j.ijantimicag.2010.08.010.
71. Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montage JR. 1996. Fungal infections: a growing threat. Public Health Rep. 111:226-235. (Pubitemid 26149570)
72. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10:48-66. http://dx.doi.org/10.1111/j.1470-9465.2004. 00839.x. (Pubitemid 38379951)
73. Odds FC, Bougnoux ME, Shaw DJ, Bain JM, Davidson AD, Diogo D, Jacobsen MD, Lecomte M, Li SY, Tavanti A, Maiden MCJ, Gow NAR, d'Enfert C. 2007. Molecular phylogenetics of Candida albicans. Eukaryot. Cell 6:1041-1052. http://dx.doi.org/10.1128/EC.00041-07. (Pubitemid 46983303)
74. Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, Munro CA, Rheinbay E, Grabherr M, Forche A, Reedy JL, Agrafioti I, Arnaud MB, Bates S, Brown AJ, Brunke S, Costanzo MC, Fitzpatrick DA, de Groot PW, Harris D, Hoyer LL, Hube B, Klis FM, Kodira C, Lennard N, Logue ME, Martin R, Neiman AM, Nikolaou E, Quail MA, Quinn J, Santos MC, Schmitzberger FF, Sherlock G, Shah P, Silverstein KA, Skrzypek MS, Soll D, Staggs R, Stansfield I, Stumpf MP, Sudbery PE, Srikantha T, Zeng Q, Berman J, Berriman M, Heitman J, Gow NA, Lorenz MC, Birren BW, Kellis M, Cuomo CA. 2009. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459:657-662. http://dx.doi.org/10. 1038/nature08064.
75. Habib N, Wapinski I, Margalit H, Regev A, Friedman N. 2012. A functional selection model explains evolutionary robustness despite plasticity in regulatory networks. Mol. Syst. Biol. 8:619. http://dx.doi.org/10.1038/msb.2012. 50.
76. Hazen KC, Baron EJ, Colombo AL, Girmenia C, Sanchez-Sousa A, del Palacio A, de Bedout C, Gibbs DL. 2003. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J. Clin. Microbiol. 41:5623-5632. http://dx.doi.org/10.1128/JCM.41. 12.5623-5632.2003. (Pubitemid 37543257)
77. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921. http://dx.doi.org/10.1128/AAC.50.3.917-921.2006. (Pubitemid 43327795)
78. Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Buisson M, Camerlynck P, Portier H. 1994. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 8:945-950. http://dx.doi.org/10.1097/00002030-199407000-00011. (Pubitemid 24206604)
79. Ruhnke M, Eigler A, Geiseler B, Engelmann E, Trautmann M. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098. (Pubitemid 24258446)
80. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC. 2004. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 4:369-376. http://dx.doi.org/10.1016/S1567-1356(03)00240-X.
81. Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. 2012. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infect. Dis. 12:230. http://dx.doi.org/10.1186/1471-2334-12-230.
82. Hof H, Eigner U, Maier T, Staib P. 2012. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometry. Clin. Lab. 58:927-931.